Maverix Biomics Raises $6M in Series A Round | GenomeWeb

NEW YORK (GenomeWeb News) – Bioinformatics firm Maverix Biomics today announced it raised $6 million in a Series A financing round to support the continued commercialization of its recently launched data analysis platform.

The financing was led by Asset Management Ventures and individual investors Andreas Bechtolsheim and Andrew Yang. In conjunction with the financing, Yang and Louis Lange, a general partner at Asset Management, have joined Maverix's board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.

Wired's Sarah Zhang writes that the fight over who developed the CRISPR/Cas9 genome editing tool first underscores the history of parallel discoveries in science.

Recent research indicates that the benefit of having a number of scientists all living and working in a certain area is eroding.

Tomas Lindahl, Paul Modrich, and Aziz Sancar share this year's Nobel Prize in Chemistry for their studies of DNA repair mechanisms.

Sponsored by
Oracle Health Sciences

Brian Wells of Penn Medicine will detail how his team's "PennOmics" integrated healthcare data warehouse accelerates clinical trial recruitment at the point of care, accepts data from wearables, and does it all in a secure, HIPAA- and research-compliant fashion.